Biblio
Export 298 results:
[ Author] Title Type Year Filters: First Letter Of Last Name is S [Clear All Filters]
“The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 809-18, 2016.
, “Relationships between Cognition and Activities of Daily Living in Alzheimer's Disease During a 5-Year Follow-Up: ALSOVA Study.”, J Alzheimers Dis, vol. 64, no. 1, pp. 269-279, 2018.
, “Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 2, pp. 441-446, 2017.
, “Exercise Plus Cognitive Performance Over and Above Exercise Alone in Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 1, pp. 19-25, 2016.
, “Increased Risk of Dementia in Subjective Cognitive Decline if CT Brain Changes are Present.”, J Alzheimers Dis, vol. 66, no. 2, pp. 483-495, 2018.
, “Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles.”, J Alzheimers Dis, vol. 58, no. 2, pp. 463-470, 2017.
, “The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 2, pp. 753-775, 2024.
, “Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy.”, J Alzheimers Dis, vol. 64, no. s1, pp. S353-S359, 2018.
, “Flickering Red-Light Stimulus for Promoting Coherent 40 Hz Neural Oscillation: A Feasibility Study.”, J Alzheimers Dis, vol. 75, no. 3, pp. 911-921, 2020.
, “TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1227-1233, 2018.
, “First Biodistribution Study of [68Ga]Ga-NOTA-Insulin Following Intranasal Administration in Adult Vervet Monkeys.”, J Alzheimers Dis, vol. 101, no. 1, pp. 309-320, 2024.
, “Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 1, pp. 59-65, 2017.
, “Cross-Sectional Analysis of Periodontal Disease and Cognitive Impairment Conducted in a Memory Clinic: The Pearl Study.”, J Alzheimers Dis, vol. 96, no. 1, pp. 369-380, 2023.
, “Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures.”, J Alzheimers Dis, vol. 70, no. 3, pp. 659-666, 2019.
, “Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid.”, J Alzheimers Dis, vol. 51, no. 4, pp. 997-1002, 2016.
, “Job Loss After Diagnosis of Early-Onset Dementia: A Matched Cohort Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1231-1235, 2017.
, “Impaired IL-17 Production in Gut-Residing Immune Cells of 5xFAD Mice with Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 61, no. 2, pp. 619-630, 2018.
, “Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 3, pp. 909-918, 2017.
, “Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition.”, J Alzheimers Dis, vol. 58, no. 3, pp. 829-840, 2017.
, “Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock-In Mice.”, J Alzheimers Dis, vol. 66, no. 2, pp. 801-809, 2018.
, “A Lipidomics Approach to Assess the Association Between Plasma Sphingolipids and Verbal Memory Performance in Coronary Artery Disease Patients Undertaking Cardiac Rehabilitation: A C18:0 Signature for Cognitive Response to Exercise.”, J Alzheimers Dis, vol. 60, no. 3, pp. 829-841, 2017.
, “Moving from the Dish to the Clinical Practice: A Decade of Lessons and Perspectives from the Pre-Clinical and Clinical Stem Cell Studies for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1209-30, 2016.
, “Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis.”, J Alzheimers Dis, vol. 92, no. 1, pp. 129-139, 2023.
, “Subclinical Doses of ATP-Sensitive Potassium Channel Modulators Prevent Alterations in Memory and Synaptic Plasticity Induced by Amyloid-β.”, J Alzheimers Dis, vol. 57, no. 1, pp. 205-226, 2017.
, “Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study.”, J Alzheimers Dis, vol. 64, no. 3, pp. 689-707, 2018.
,